Gray matter differences contribute to variation in cognitive performance in Parkinson's disease

European Journal of Neurology

Volumn 21, Issue 2, 2014, Pages 245-252

  Gerrits, N J H M ^a   van der Werf, Y D ^a,b   Hofman, M ^a   Foncke, E M J ^a   Klein, M ^a   Berendse, H W ^a   van den Heuvel, O A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Cognitive deficits; Parkinson's disease; Structural MRI; Voxel based morphometry

Indexed keywords

ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BRAIN SIZE; COGNITION; EXECUTIVE FUNCTION; FRONTAL CORTEX; FRONTAL LOBE; GLOBUS PALLIDUS; GRAY MATTER; HOEHN AND YAHR SCALE; HUMAN; INFERIOR TEMPORAL GYRUS; LEARNING; MAJOR CLINICAL STUDY; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; OCCIPITAL LOBE; PARAHIPPOCAMPAL GYRUS; PARIETAL CORTEX; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; STROOP TEST; SUPERIOR FRONTAL GYRUS; TEMPORAL CORTEX; TEMPORAL LOBE; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL MEMORY; VOXEL BASED MORPHOMETRY;

COGNITIVE DEFICITS; PARKINSON'S DISEASE; STRUCTURAL MRI; VOXEL-BASED MORPHOMETRY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; COGNITION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, UNMYELINATED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84892482550     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12269     Document Type: Article

References (37)

1. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8: 464-474.
2. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-1245.
3. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010; 9: 1200-1213.
4. Grahn JA, Parkinson JA, Owen AM. The role of the basal ganglia in learning and memory: neuropsychological studies. Behav Brain Res 2009; 199: 53-60.
5. Monchi O, Petrides M, Mejia-Constain B, Strafella AP. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 2007; 130: 233-244.
6. Madsen K, Erritzoe D, Mortensen EL, et al. Cognitive function is related to fronto-striatal serotonin transporter levels - a brain PET study in young healthy subjects. Psychopharmacology 2011; 213: 573-581.
7. Vazey EM, Aston-Jones G. The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease. Front Behav Neurosci 2012; 6: 48.
8. Ibarretxe-Bilbao N, Junque C, Marti MJ, Tolosa E. Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease. J Neurol Sci 2011; 310: 70-74.
9. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
10. Melzer TR, Watts R, MacAskill MR, et al. Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83: 188-194.
11. Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord 2011; 26: 289-296.
12. Pan PL, Song W, Shang HF. Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson's disease. Eur J Neurol 2012; 19: 199-206.
13. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993; 39: 165-172.
14. Verhage F. Het coderen van het opleidingsniveau voor researchdoeleinden [Educational Classification System for Research Purposes: Revised Version]. Internal publication. Groningen, the Netherlands: Academic Hospital Groningen, State University Groningen, 1983.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
16. Fahn S, Elton RL, Committee MotUD. Unified Parkinson′s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson′s Disease. Florham Park, NJ: Macmillan Healthcare Information, 1987: 153/164.
17. Olde Dubbelink KT, Stoffers D, Deijen JB, Twisk JW, Stam CJ, Berendse HW. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol Aging 2013; 34: 408-418.
18. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984; 40: 1365-1367.
19. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893-897.
20. Rey A. L′examen clinique en psychologie. Paris: Presses Universitaires de France, 1964.
21. Osterrieth PA. Le test du copie d'une figure complexe. Arch Psychol (Chicago) 1944; 30: 206-356.
22. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-662.
23. Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol 1955; 19: 393-394.
24. Sanchez-Cubillo I, Perianez JA, Adrover-Roig D, et al. Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc 2009; 15: 438-450.
25. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95-113.
26. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-1239.
27. Lee TM, Yip JT, Jones-Gotman M. Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review. Epilepsia 2002; 43: 283-291.
28. Keane MM, Gabrieli JD, Mapstone HC, Johnson KA, Corkin S. Double dissociation of memory capacities after bilateral occipital-lobe or medial temporal-lobe lesions. Brain 1995; 118(Pt 5): 1129-1148.
29. Kwok SC, Shallice T, Macaluso E. Functional anatomy of temporal organisation and domain-specificity of episodic memory retrieval. Neuropsychologia 2012; 50: 2943-2955.
30. Squarzoni P, Tamashiro-Duran J, Souza Duran FL, et al. Relationship between regional brain volumes and cognitive performance in the healthy aging: an MRI study using voxel-based morphometry. J Alzheimers Dis 2012; 31: 45-58.
31. Bonelli SB, Powell R, Thompson PJ, et al. Hippocampal activation correlates with visual confrontation naming: fMRI findings in controls and patients with temporal lobe epilepsy. Epilepsy Res 2011; 95: 246-254.
32. Henry JD, Crawford JR. A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology 2004; 18: 284-295.
33. Pereira JB, Junque C, Marti MJ, Ramirez-Ruiz B, Bartres-Faz D, Tolosa E. Structural brain correlates of verbal fluency in Parkinson's disease. NeuroReport 2009; 20: 741-744.
34. Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 2006; 16: 17-42.
35. Jubault T, Monetta L, Strafella AP, Lafontaine AL, Monchi O. L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network. PLoS One 2009; 4: e6154.
36. Martin WR, Wieler M, Gee M, Camicioli R. Temporal lobe changes in early, untreated Parkinson's disease. Mov Disord 2009; 24: 1949-1954.
37. Farrar DE, Glauber RR. Multicollinearity in regression analysis: the problem revisited. Rev Econ Stat 1963; 49: 92-107.